Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
ClinicalTrials.gov study NCT01838018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study
ClinicalTrials.gov study NCT06463626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00560716. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period
ClinicalTrials.gov study NCT05175105. IPD Sharing: NO. Countries: 7. Publications: 0.
Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
ClinicalTrials.gov study NCT06585059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT01110083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnoses Associated With Persistent Elevation of Creatine Kinase
ClinicalTrials.gov study NCT04838509. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rho Kinase in Patients With Atherosclerosis
ClinicalTrials.gov study NCT00115830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
ClinicalTrials.gov study NCT01460537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory Leukemias
ClinicalTrials.gov study NCT01239108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
ClinicalTrials.gov study NCT06140836. IPD Sharing: Not stated. Countries: 21. Publications: 0.
PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)
ClinicalTrials.gov study NCT01536821. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
ClinicalTrials.gov study NCT05438420. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma
ClinicalTrials.gov study NCT02152774. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Tor Kinase Inhibitor in Advanced Tumors
ClinicalTrials.gov study NCT00731263. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT06520098. IPD Sharing: NO. Countries: 1. Publications: 0.
Extracellular Signal-Related Kinase Biomarker Development in Autism
ClinicalTrials.gov study NCT01850459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT02463305. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
ClinicalTrials.gov study NCT07271667. IPD Sharing: NO. Countries: 0. Publications: 0.
Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT00243854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.